Orencia Becomes First Biologic Available as Injection or Infusion for Rheumatoid Arthritis

Bristol-Myers Squibb received FDA approval to market a new formulation of Orencia (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.
About